CytomX Therapeutics Inc (CTMX) — Cash Flow Reinvestment Rate
CytomX Therapeutics Inc (CTMX) has a Cash Flow Reinvestment Rate of 15.69x as of March 2023, reinvesting $146.64 Million (capex $48.00K plus investments $-146.59 Million) from operating cash flow of $9.35 Million. Explore reinvestment intensity of CytomX Therapeutics Inc to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
CytomX Therapeutics Inc Cash Flow Reinvestment Rate (2014–2020)
Historical reinvestment intensity for CytomX Therapeutics Inc across 3 annual periods. Also explore CytomX Therapeutics Inc (CTMX) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for CytomX Therapeutics Inc (2014–2020)
Year-by-year capital reinvestment analysis for CytomX Therapeutics Inc. For live market cap and broader valuation context, see CTMX company net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 3.56x | $18.72 Million | $5.26 Million | $2.31 Million | ▲ +393.7% |
| 2017 | 0.72x | $122.83 Million | $170.37 Million | $1.56 Million | ▼ -82.3% |
| 2014 | 4.08x | $129.81 Million | $31.80 Million | $1.66 Million | — |